BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31202670)

  • 1. Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia.
    Muhsen IN; Alahmari A; Alnahedh M; Alkhudair NA; Samarkandi H; El Fakih R
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):251-254. PubMed ID: 31202670
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura.
    Gurlek Gokcebay D; Guzelkucuk Z; Yarali N
    Transfus Apher Sci; 2018 Jun; 57(3):416-417. PubMed ID: 29753699
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A
    Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anemia and hemorrhagic diathesis in autoimmune hemolysis and immune thrombocytopenia].
    Stemmler HJ; Ochmann O; Pihusch R; Hiller E
    Internist (Berl); 1996 Jan; 37(1):78-81. PubMed ID: 8837831
    [No Abstract]   [Full Text] [Related]  

  • 5. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C
    Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare case of autoimmune hepatitis overlapping with autoimmune haemolytic anaemia and immune thrombocytopenic purpura in a male patient.
    Shanthi P; Sridhar R
    Med J Malaysia; 2012 Jun; 67(3):326-8. PubMed ID: 23082427
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of Evans syndrome with Tacrolimus.
    Tabchi S; Hanna C; Kourie HR; Aftimos P; El Osta L; Ghosn M
    Invest New Drugs; 2015 Feb; 33(1):254-6. PubMed ID: 25209619
    [No Abstract]   [Full Text] [Related]  

  • 8. Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura.
    Beckman JD; Rollins-Raval MA; Raval JS; Park YA; Mazepa M; Ma A
    Am J Ther; 2018; 25(2):e270-e272. PubMed ID: 29293474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of lupus erythematosus following splenectomy in idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.
    DAMESHEK W; REEVES WH
    Am J Med; 1956 Oct; 21(4):560-6. PubMed ID: 13362287
    [No Abstract]   [Full Text] [Related]  

  • 10. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia.
    Conti F; Gottardi F; Moratti M; Belotti T; Ferrari S; Selva P; Bassi M; Zama D; Pession A
    Platelets; 2022 Jul; 33(5):801-806. PubMed ID: 35132908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
    Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
    Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective cyclosporine therapy to resistant-Evans syndrome].
    Tsudo M; Moriguchi T
    Rinsho Ketsueki; 1996 Nov; 37(11):1289-92. PubMed ID: 8960663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Hbibi M; El Alaoui El Hanafi M; Kasmi Z; Ouair H; Benmiloud S; Ailal F; Hida M; Bousfiha AA
    Tunis Med; 2024 Jan; 102(1):1-6. PubMed ID: 38545722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders.
    Funato K; Kuriyama Y; Uchida Y; Suzuki A; Miyazawa K; Ohyashiki K
    Intern Med; 2001 Oct; 40(10):1041-4. PubMed ID: 11688831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fostamatinib: First Global Approval.
    Markham A
    Drugs; 2018 Jun; 78(9):959-963. PubMed ID: 29869203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura.
    Howard J; Hoffbrand AV; Prentice HG; Mehta A
    Br J Haematol; 2002 Jun; 117(3):712-5. PubMed ID: 12028047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe neonatal autoimmune thrombocytopenia secondary to maternal Evans syndrome.
    Beryl S; Ross BJ; Tergestina M; Kumar M
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34857590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic thrombopenic purpura associated with an autoimmune hemolytic anemia or Fisher-Evans syndrome: apropos of a case].
    Ndiaye O; Sylla A; Ndiaye FS; Diagne I; Diallo-Chauvin M; Diouf S; Sallm G; Kuakuvi K
    Dakar Med; 1999; 44(2):240-2. PubMed ID: 11957294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.